# US 2017/0281608 A1 · Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281608 A1
- Document ID: US20170281608A1
- Status: Published application
- Kind: A1
- Application number: 15/627,871
- Filed: 2017-06-20
- Published: 2017-10-05
- Earliest claimed: 2009-08-11
- Assignees: Acorda Therapeutics, Inc.
- Applicants: Acorda Therapeutics, Inc.
- Inventors: Thomas C. Wessel; Andrew R. Blight
- Web page: https://patentgrep.com/patent/US20170281608A1

## CPC

- A61K 31/4409: only substituted in position 4, e.g. isoniazid, iproniazid
- A61K 31/44: Non condensed pyridines; Hydrogenated derivatives thereof
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed herein are methods and compositions related to use of aminopyridines, such as 4-aminopyridine, to improve the neuro-cognitive impairments and related neuro-psychiatric impairments of patients with a demyelinating condition such as MS, traumatic brain injury, cerebral palsy, post-radiation encephalopathy.

## Claims

### Claim 1

A method of dosing of an aminopyridine to improve at least one neuro-cognitive or neuro-psychiatric parameter in a patient.

### Claim 2 (depends on 1)

The method of claim 1 wherein the patient has demyelinating condition, MS, traumatic brain injury, cerebral palsy or post-radiation encephalopathy.

### Claim 3 (depends on 3)

The method of claim 3 wherein the patient has a MS.

### Claim 4 (depends on 1)

The method of claim 1 wherein the treatment takes place for at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, or more than 12 weeks.

### Claim 5 (depends on 1)

The method of claim 1 wherein the aminopyridine is 4-aminopyridine.

### Claim 6 (depends on 1)

The method of claim 1 wherein the aminopyridine is Fampridine-SR.

### Claim 7 (depends on 6)

The method of claim 6, wherein the Fampridine-SR is dosed 10 mg bid.

### Claim 8 (depends on 1)

The method of claim 1, in combination with another therapeutic modality to address a neuro-cognitive or neuro-psychiatric disorder.

### Claim 9 (depends on 1)

The method of claim 1, wherein the patient has MS, and the method comprising administering in combination with another therapeutic modality to address MS.

### Claim 10 (depends on 1)

A method of claim 1, further comprising a step of identifying that a patient has a neuro-cognitive or neuro-psychiatric impairment.

### Claim 11

A method of treating a neuro-cognitive or neuro-psychiatric disorder, said method comprising:
providing a patient that a patient has a neuro-cognitive or neuro-psychiatric disorder, identifying a patient that a patient has a neuro-cognitive or neuro-psychiatric disorder or diagnosing that a patient has a neuro-cognitive or neuro-psychiatric disorder; and
administering a regimen of dosing an aminopyridine to improve at least one neuro-cognitive or neuro-psychiatric parameter in a patient.

### Claim 12 (depends on 11)

The method of claim 11 wherein the administering step comprises prescribing a regimen of dosing an aminopyridine to improve at least one neuro-cognitive or neuro-psychiatric parameter in a patient.

### Claim 13 (depends on 11)

The method of claim 11 wherein the aminopyridine is 4-aminopyridine.

### Claim 14

A method of preparing a medicament for use in a method if treating a neuro-cognitive or neuro-psychiatric disorder, wherein the method in which the medicament is used comprises:
providing a patient that a patient has a neuro-cognitive or neuro-psychiatric disorder, identifying a patient that a patient has a neuro-cognitive or neuro-psychiatric disorder or diagnosing that a patient has a neuro-cognitive or neuro-psychiatric disorder; and
administering a regimen of dosing an aminopyridine to improve at least one neuro-cognitive or neuro-psychiatric parameter in a patient.

### Claim 15 (depends on 14)

The method of claim 14 wherein the administering step comprises prescribing a regimen of dosing an aminopyridine to improve at least one neuro-cognitive or neuro-psychiatric parameter in a patient.

### Claim 16

A method of treating a neuro-cognitive or neuro-psychiatric disorder substantially as described herein.

### Claim 17

A method for preparing a medicament for use in a method for treating a neuro-cognitive or neuro-psychiatric disorder substantially as described herein.
